Podcast: Regulus Therapeutics and microRNA Drug Delivery - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and microRNA Drug Delivery


blog comments powered by Disqus


BioPharm International interviews Bal Bhat, senior director and head of chemistry at Regulus, whose core technology focuses on microRNA drug delivery. Bhat addresses some of the challenges of using microRNA therapeutically and explains Regulus’ conscious decision to use single-stranded microRNA. The possibility of targeting specific tissues using a local delivery system or a packaging molecule is also discussed. Finally, Bhat describes the reactions of potential pharma partners to Regulus’ research data and how the project will move forward.

Related article on Perspectives in MicroRNA Therapeutics

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here